Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Combination hormone therapy doubles breast density and quadruples risk of abnormal mammograms

19.10.2004


Postmenopausal women who take combination estrogen-plus-progestin hormone-replacement therapy for one year experience a twofold increase in breast density – a known risk factor for breast cancer – and a quadrupled risk of having an abnormal mammogram, according to new findings from a sub-study of the Women’s Health Initiative, or WHI.



Lead investigator Anne McTiernan, M.D., Ph.D., of Fred Hutchinson Cancer Research Center, presented these findings today at the third annual International Conference on Frontiers in Cancer Prevention Research hosted by the American Association for Cancer Research. "I was surprised by the magnitude of the effect – the doubling of breast density associated with combination-hormone therapy," said McTiernan, a member of Fred Hutchinson’s Public Health Sciences Division and lead physician of the WHI Clinical Coordinating Center, which is based at Fred Hutchinson.

The effect of HRT on breast density remained consistent throughout the two-year study period and was similar across ethnic and racial groups. The impact was particularly pronounced among women in the highest age bracket; those between 70 and 79 experienced a nearly threefold increase in breast density as compared to younger women, presumably because their breast tissue was less dense to begin with, McTiernan said. "These findings are unique in showing a sustained effect over two years and that even in older postmenpausal women breast density can increase in response to estrogen-plus-progestin therapy," McTiernan said.


The study involved a randomly selected subgroup of 413 racially and ethnically diverse postmenopausal women, ages 50 to 79, who were participants in the WHI estrogen plus progestin trial, which involved more than 16,500 women nationwide. Half of the women in the sub-study were randomly selected to receive estrogen plus progestin and half received an identical-looking placebo. All received a baseline mammogram at the beginning of the study and a follow-up mammogram after one or two years.

On average, participants were 62 years old and 12 years post-menopause at the beginning of the study. The majority of the women were non-Hispanic white (42 percent) or African-American (35 percent), 16 percent were Hispanic and 6 percent were Asian/Pacific Islander.

Breast density was measured by a computer-aided technique that calculated the amount of dense, or white-appearing, tissue on digitized mammography images. A woman’s risk of breast cancer and her chances of getting an accurate cancer diagnosis depend largely on the density of her breast tissue. Density is measured according to the ratio of connective and epithelial tissue, which appears on a mammogram as white; as compared to fatty tissue, which appears as black. Because cancer also appears as white on a mammogram, a high degree of breast density can make it difficult to spot tumors and other abnormalities.

In addition to being harder to image, dense breast tissue also appears to be more biologically active and susceptible to malignancy. Previous research at Fred Hutchinson has shown that women under 50 with predominantly dense breasts are four times more likely to develop breast cancer than those with little or no breast density. While density is determined largely by age and genetics, this study underscores the fact that other factors can play a part as well. In addition to hormone-replacement therapy, weight and physical activity also have been found to have an impact on breast density.

"By increasing breast density, the use of combination estrogen-plus-progestin hormone therapy may increase breast-cancer risk as well as decrease the sensitivity of screening mammography," McTiernan said. "Our results suggest that avoiding such hormone therapy may help improve the sensitivity of mammograms for detecting early breast cancers at a stage when they are most treatable."

In addition, McTiernan and colleagues suggest that health-care providers may want to track breast-density change during regular mammography screenings and use this information as part of the risk-benefit assessment when helping women choose whether to continue hormone therapy.

Warren Froelich | EurekAlert!
Further information:
http://www.aacr.org

More articles from Health and Medicine:

nachricht Speed data for the brain’s navigation system
06.12.2016 | Deutsches Zentrum für Neurodegenerative Erkrankungen e.V. (DZNE)

nachricht Study suggests possible new target for treating and preventing Alzheimer's
02.12.2016 | Oregon Health & Science University

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Significantly more productivity in USP lasers

In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.

Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...

Im Focus: Shape matters when light meets atom

Mapping the interaction of a single atom with a single photon may inform design of quantum devices

Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

Simple processing technique could cut cost of organic PV and wearable electronics

06.12.2016 | Materials Sciences

3-D printed kidney phantoms aid nuclear medicine dosing calibration

06.12.2016 | Medical Engineering

Robot on demand: Mobile machining of aircraft components with high precision

06.12.2016 | Power and Electrical Engineering

VideoLinks
B2B-VideoLinks
More VideoLinks >>>